Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes
Open Access
- 16 December 2019
- journal article
- research article
- Published by Elsevier BV in Annals of Hepatology
- Vol. 19 (3), 320-328
- https://doi.org/10.1016/j.aohep.2019.11.008
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81660399, 81860423)
- Innovative Research Team Project of Yunnan Province (2015HC033)
- Yunnan Provincial Academician Workstation of Xiaoping Chen (2017IC018)
- Breeding Program for Major Scientific and Technological Achievements of Kunming Medical University (CGYP201607)
- Medical Leading Talent Project of Yunnan Province (L201622)
- Yunnan Provincial Clinical Center of Hepato-biliary-pancreatic Diseases (ZX2019-04-04)
- Leading Academic and Technical Young and Mid-aged Program of Kunming Medical University (60118260108)
- Educational Research and Educational Reform Program of Kunming Medical University (2019-JY-Z-12)
This publication has 27 references indexed in Scilit:
- Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenibExpert Opinion on Pharmacotherapy, 2015
- Diabetes Mellitus and Poorer Prognosis in Hepatocellular Carcinoma: A Systematic Review and Meta-AnalysisPLOS ONE, 2014
- Metformin does not improve survival in patients with hepatocellular carcinomaWorld Journal of Gastroenterology, 2014
- Prognostic Significance of AMPK Activation and Therapeutic Effects of Metformin in Hepatocellular CarcinomaClinical Cancer Research, 2013
- Insulin receptor tyrosine kinase substrate activates EGFR/ERK signalling pathway and promotes cell proliferation of hepatocellular carcinomaCancer Letters, 2013
- Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studiesGut, 2012
- Diabetes UK evidence‐based nutrition guidelines for the prevention and management of diabetesDiabetic Medicine, 2011
- Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablationJournal of Gastroenterology and Hepatology, 2011
- Diabetes mellitus impairs the response to intra-arterial chemotherapy in hepatocellular carcinomaMedical Oncology, 2010
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007